Personal information

No personal information available

Activities

Collapse all

Employment (3)

University Medical Center Utrecht: Utrecht, NL

2024-03-01 to present | Assistant Professor (Julius Center for Health Sciences and Primary Care, Department of Datascience & Biostatistics)
Employment
Source: Self-asserted source
Linda Nab

University of Oxford: Oxford, Oxfordshire, GB

2022-01-10 to 2024-01-31 | Epidemiologist (Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences)
Employment
Source: Self-asserted source
Linda Nab

Leiden University Medical Center: Leiden, Zuid-Holland, NL

2017-10-01 to 2021-12-31 | Phd Student (Clinical Epidemiology)
Employment
Source: Self-asserted source
Linda Nab

Education and qualifications (2)

Wageningen University & Research: Wageningen, Gelderland, NL

2015-09-01 to 2017-08-31 | Msc (Nutrition and Health)
Education
Source: Self-asserted source
Linda Nab

Utrecht University: Utrecht, Utrecht, NL

2009-09-01 to 2013-08-31 | Bsc (Mathematics)
Education
Source: Self-asserted source
Linda Nab

Works (17)

OpenSAFELY: A platform for analysing electronic health records designed for reproducible research

Pharmacoepidemiology and Drug Safety
2024-06 | Journal article
DOI: 10.1002/pds.5815
Contributors: Linda Nab; Andrea L. Schaffer; William Hulme; Nicholas J. DeVito; Iain Dillingham; Milan Wiedemann; Colm D. Andrews; Helen Curtis; Louis Fisher; Amelia Green et al.
Source: check_circle
Crossref

Changes in opioid prescribing during the COVID-19 pandemic in England: cohort study of 20 million patients in OpenSAFELY-TPP

2024-02-24 | Preprint
DOI: 10.1101/2024.02.23.24303238
Contributors: Andrea L Schaffer; Colm D Andrews; Andrew D Brown; Richard Croker; William J Hulme; Linda Nab; Jane Quinlan; Victoria Speed; Christopher Wood; Milan Wiedemann et al.
Source: check_circle
Crossref

OpenSAFELY: a platform for analysing electronic health records designed for reproducible research

2024-02-03 | Preprint
DOI: 10.31219/osf.io/hj2sg
Contributors: Linda Nab; Andrea Schaffer; William J Hulme; Nicholas J DeVito; Iain Dillingham; Milan Wiedemann; Colm Andews; Helen Curtis; Louis Fisher; Amelia Green et al.
Source: check_circle
Crossref

Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform

The Lancet Public Health
2023-05 | Journal article
DOI: 10.1016/s2468-2667(23)00079-8
Part of ISSN: 2468-2667
Contributors: Linda Nab; Edward P K Parker; Colm D Andrews; William J Hulme; Louis Fisher; Jessica Morley; Amir Mehrkar; Brian MacKenna; Peter Inglesby; Caroline E Morton et al.
Source: Self-asserted source
Linda Nab

Effectiveness of Sotrovimab and Molnupiravir in community settings in England across the Omicron BA.1 and BA.2 sublineages: emulated target trials using the OpenSAFELY platform

2023-05-16 | Preprint
DOI: 10.1101/2023.05.12.23289914
Contributors: John Tazare; Linda Nab; Bang Zheng; William J Hulme; Amelia C A Green; Helen J Curtis; Viyaasan Mahalingasivam; Rose Higgins; Anna Schultze; Krishnan Bhaskaran et al.
Source: check_circle
Crossref

Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study

BMJ Open
2023-01 | Journal article
DOI: 10.1136/bmjopen-2022-066164
Part of ISSN: 2044-6055
Part of ISSN: 2044-6055
Contributors: The OpenSAFELY Collaborative; Edward PK Parker; John Tazare; William J Hulme; Christopher Bates; Edward J Carr; Jonathan Cockburn; Helen Curtis; Louis Fisher; Amelia CA Green et al.
Source: Self-asserted source
Linda Nab

Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY

BMJ Medicine
2023-01 | Journal article
DOI: 10.1136/bmjmed-2022-000276
Part of ISSN: 2754-0413
Contributors: Amelia C A Green; Helen J Curtis; Rose Higgins; Linda Nab; Viyaasan Mahalingasivam; Rebecca M Smith; Amir Mehrkar; Peter Inglesby; Henry Drysdale; Nicholas J DeVito et al.
Source: Self-asserted source
Linda Nab

Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform

BMJ
2022-11-16 | Journal article
DOI: 10.1136/bmj-2022-071932
Part of ISSN: 1756-1833
Contributors: Bang Zheng; Amelia C A Green; John Tazare; Helen J Curtis; Louis Fisher; Linda Nab; Anna Schultze; Viyaasan Mahalingasivam; Edward P K Parker; William J Hulme et al.
Source: Self-asserted source
Linda Nab

Estimating incidence of venous thromboembolism in COVID‐19: Methodological considerations

Research and Practice in Thrombosis and Haemostasis
2022-08 | Journal article
DOI: 10.1002/rth2.12776
Part of ISSN: 2475-0379
Contributors: Linda Nab; Rolf Groenwold; F.A. Klok; Soerajja Bhoelan; Marieke Kruip; Suzanne Cannegieter
Source: Self-asserted source
Linda Nab

Changes in COVID-19-related mortality across key demographic and clinical subgroups: an observational cohort study using the OpenSAFELY platform on 18 million adults in England

2022-08-02 | Preprint
DOI: 10.1101/2022.07.30.22278161
Contributors: Linda Nab; Edward PK Parker; Colm D Andrews; William J Hulme; Louis Fisher; Jessica Morley; Amir Mehrkar; Brian MacKenna; Peter Inglesby; Caroline E Morton et al.
Source: check_circle
Crossref

Effectiveness of BNT162b2 booster doses in England: an observational study in OpenSAFELY-TPP

2022-06-06 | Preprint
DOI: 10.1101/2022.06.06.22276026
Contributors: William J Hulme; Elizabeth J Williamson; Elsie Horne; Amelia Green; Linda Nab; Ruth Keogh; Edward PK Parker; Venexia Walker; Tom Palmer; Helen Curtis et al.
Source: check_circle
Crossref

Sensitivity analysis for random measurement error using regression calibration and simulation-extrapolation

Global Epidemiology
2021-11 | Journal article
DOI: 10.1016/j.gloepi.2021.100067
Part of ISSN: 2590-1133
Contributors: Linda Nab; Rolf H.H. Groenwold
Source: Self-asserted source
Linda Nab

Mecor: An R package for measurement error correction in linear regression models with a continuous outcome

Computer Methods and Programs in Biomedicine
2021-09 | Journal article | Author
DOI: 10.1016/j.cmpb.2021.106238
Part of ISSN: 0169-2607
Contributors: Linda Nab; Maarten van Smeden; Ruth H. Keogh; Rolf H.H. Groenwold
Source: Self-asserted source
Linda Nab
grade
Preferred source (of 2)‎

Sampling Strategies for Internal Validation Samples for Exposure Measurement–Error Correction: A Study of Visceral Adipose Tissue Measures Replaced by Waist Circumference Measures

American Journal of Epidemiology
2021-09-01 | Journal article
DOI: 10.1093/aje/kwab114
Part of ISSN: 0002-9262
Part of ISSN: 1476-6256
Contributors: Linda Nab; Maarten van Smeden; Renée de Mutsert; Frits R Rosendaal; Rolf H H Groenwold
Source: Self-asserted source
Linda Nab

Approaches to addressing missing values, measurement error, and confounding in epidemiologic studies

Journal of Clinical Epidemiology
2021-03 | Journal article
DOI: 10.1016/j.jclinepi.2020.11.006
Part of ISSN: 0895-4356
Contributors: Maarten van Smeden; Bas B.L. Penning de Vries; Linda Nab; Rolf H.H. Groenwold
Source: Self-asserted source
Linda Nab

Quantitative Bias Analysis for a Misclassified Confounder

Epidemiology
2020-11 | Journal article
DOI: 10.1097/ede.0000000000001239
Part of ISSN: 1044-3983
Contributors: Linda Nab; Rolf H. H. Groenwold; Maarten van Smeden; Ruth H. Keogh
Source: Self-asserted source
Linda Nab

Measurement error in continuous endpoints in randomised trials: Problems and solutions

Statistics in Medicine
2019-11-30 | Journal article | Author
DOI: 10.1002/sim.8359
Part of ISSN: 0277-6715
Part of ISSN: 1097-0258
Contributors: Linda Nab; Rolf Groenwold; P.M.J. Welsing; Maarten van Smeden
Source: Self-asserted source
Linda Nab
grade
Preferred source (of 2)‎

Peer review (2 reviews for 1 publication/grant)

Review activity for PloS one. (2)
How many people are using ORCID?